<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04483804</url>
  </required_header>
  <id_info>
    <org_study_id>SAHZhejiangU---Breast</org_study_id>
    <nct_id>NCT04483804</nct_id>
  </id_info>
  <brief_title>Application of Radiomics in Breast Cancer</brief_title>
  <official_title>Application of Radiomics in Correlation Between Ultrasound Characteristics and Pathological Prognostic Factors in Breast Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Second Affiliated Hospital, School of Medicine, Zhejiang University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Second Affiliated Hospital, School of Medicine, Zhejiang University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Little is known about the correlation between ultrasound characteristics (conventional,
      elastography and contrast enhanced ultrasound (CEUS) )and pathological prognostic factors in
      breast cancer. The aim of this study was to explore the correlation between ultrasound
      characteristics and pathological prognostic factors using radiomics.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2018</start_date>
  <completion_date type="Anticipated">December 31, 2028</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2023</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>metastasis</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>lymph node metastasis and/or distant metastasis</description>
  </primary_outcome>
  <primary_outcome>
    <measure>death</measure>
    <time_frame>through study completion, an average of 1 year</time_frame>
    <description>death</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Ultrasound</condition>
  <condition>Elastography</condition>
  <condition>Pathology</condition>
  <condition>Radiomics</condition>
  <arm_group>
    <arm_group_label>disease free survival</arm_group_label>
    <description>Time from randomization to relapse or death due to disease progression</description>
  </arm_group>
  <arm_group>
    <arm_group_label>non-disease free survival</arm_group_label>
    <description>Time of metastasis or death</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Endocrine therapy</intervention_name>
    <description>Endocrine therapy</description>
    <arm_group_label>disease free survival</arm_group_label>
    <arm_group_label>non-disease free survival</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with breast cancer
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Clinical diagnosis of breast cancer

        Exclusion Criteria:

        Missing pathology Missing follow-up results Missing data
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Female dominated</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>pintong Huang</last_name>
    <role>Principal Investigator</role>
    <affiliation>Second Affiliated Hospital, School of Medicine, Zhejiang University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>zimei Lin</last_name>
    <phone>+8615157171799</phone>
    <email>zimei.lin@zju.edu.cn</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>jifan Chen</last_name>
    <phone>+8613605771565</phone>
    <email>jifanchen@zju.edu.cn</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>the Second Affiliated Hospital Zhejiang University School of Medicine</name>
      <address>
        <city>Hanzhou</city>
        <state>Zhejiang</state>
        <zip>310009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>zimei Lin</last_name>
      <phone>+86151517171799</phone>
      <email>zimei.lin@zju.edu.cn</email>
    </contact>
    <contact_backup>
      <last_name>jifan Chen</last_name>
      <phone>+8613605771565</phone>
      <email>jifanchen@zju.edu.cn</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>May 2020</verification_date>
  <study_first_submitted>May 13, 2020</study_first_submitted>
  <study_first_submitted_qc>July 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">July 23, 2020</study_first_posted>
  <last_update_submitted>July 20, 2020</last_update_submitted>
  <last_update_submitted_qc>July 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>individual participant data (IPD) can be shared after the main unit publish articles</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_info_type>Clinical Study Report (CSR)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>by request</ipd_time_frame>
    <ipd_access_criteria>by request</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

